AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Sjogren's syndrome: Challenges to management
Authors: Jabs, DA
Citation: Da. Jabs, Sjogren's syndrome: Challenges to management, AM J M CARE, 7(14), 2001, pp. S431-S432
Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis
Authors: Martin, BK Gilpin, AMK Jabs, DA Wu, AW
Citation: Bk. Martin et al., Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis, J CLIN EPID, 54(4), 2001, pp. 376-386
Ocular manifestations of vasculitis
Authors: Thorne, JE Jabs, DA
Citation: Je. Thorne et Da. Jabs, Ocular manifestations of vasculitis, RHEUM DIS C, 27(4), 2001, pp. 761
Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis
Authors: Holbrook, JT Meinert, CL Jabs, DA
Citation: Jt. Holbrook et al., Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis, CONTR CL TR, 22(1), 2001, pp. 62-68
The role of fas-fas ligand-mediated apoptosis in autoimmune lacrimal glanddisease in MRL/MpJ mice
Authors: Jabs, DA Lee, B Whittum-Hudson, J Prendergast, RA
Citation: Da. Jabs et al., The role of fas-fas ligand-mediated apoptosis in autoimmune lacrimal glanddisease in MRL/MpJ mice, INV OPHTH V, 42(2), 2001, pp. 399-401
Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice
Authors: Jabs, DA Prendergast, RA Rorer, EM Hudson, AP Whittum-Hudson, JA
Citation: Da. Jabs et al., Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice, INV OPHTH V, 42(11), 2001, pp. 2567-2571
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis
Authors: Jabs, DA Martin, BK Forman, MS Dunn, JP Davis, JL Weinberg, DV Biron, KK Baldanti, F
Citation: Da. Jabs et al., Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis, J INFEC DIS, 183(2), 2001, pp. 333-337
Discontinuing anticytomegalovirus therapy in patients with cytomegalovirusretinitis and AIDS
Authors: Jabs, DA
Citation: Da. Jabs, Discontinuing anticytomegalovirus therapy in patients with cytomegalovirusretinitis and AIDS, BR J OPHTH, 85(4), 2001, pp. 381-382
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease
Authors: Smith, JR Levinson, RD Holland, GN Jabs, DA Robinson, MR Whitcup, SM Rosenbaum, JT
Citation: Jr. Smith et al., Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease, ARTH RH ART, 45(3), 2001, pp. 252-257
Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients
Authors: Holbrook, JT Meinert, CL Van Natta, ML Davis, M Hubbard, L Jabs, DA
Citation: Jt. Holbrook et al., Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients, ARCH OPHTH, 119(4), 2001, pp. 554-563
Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome
Authors: Kempen, JH Jabs, DA Dunn, JP West, SK Tonascia, J
Citation: Jh. Kempen et al., Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome, ARCH OPHTH, 119(1), 2001, pp. 33-40
Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8
Authors: Jabs, DA Martin, BK Forman, MS Dunn, JP Davis, JL Weinberg, DV Biron, KK Baldanti, F Hu, HL
Citation: Da. Jabs et al., Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8, AM J OPHTH, 132(5), 2001, pp. 700-710
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
Authors: Jabs, DA Rosenbaum, JT
Citation: Da. Jabs et Jt. Rosenbaum, Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel, AM J OPHTH, 131(5), 2001, pp. 679-679
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The ganciclovir cidofovir cytomegalovirus retinitis trial
Authors: Jabs, DA
Citation: Da. Jabs, The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The ganciclovir cidofovir cytomegalovirus retinitis trial, AM J OPHTH, 131(4), 2001, pp. 457-467
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial - The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group
Authors: Lewis, RA Carr, LM Doyle, K Fainstein, V Gross, R Orengo-Nania, S Samo, TC Shigley, JW Spencer, SS Weinert, M Dunn, JP Bartlett, J Becker, R Feinberg, J Jabs, DA Johnson, DA LaSalvia, S Miller, T Neisser, LG Semba, RD Tay-Kearney, ML Tucker, P Barron, B Jarrott, C Peyman, G Swenie, D Friedman, AH Ginsburg, R Sacks, H Severin, C Teich, S Wallach, F Rescigno, R Cowan, J Horan, C Kloser, P Wanner, M Friedberg, DN Addessi, A Chachoua, A Dieterich, D Hill, J Hutt, R Ligh, J Lorenzo-Latkany, M Pei, M Powers, T Scoppe, C Weinberg, DV Jampol, LM Lyon, AT Munana, A Murphy, R Palella, F Richine, L Strugala, Z Valadez, G Holland, GN Carlson, ME Chafey, S Hardy, WD Johiro, AK MacArthur-Chang, LJ Martin, MA Moe, AA Strong, CA Tufail, A Ugalat, PS Weisz, JM Freeman, WR Arevalo-Colina, JF Clark, T Jarman, CL Meixner, L Meng, TC Spector, S Taskintuna, I Torriani, FJ O'Donnell, J Alfred, P Ballesteros, F Clay, D Coleman, R Gordon, K Gumbley, D Hoffman, J Irvine, A Jacobson, M Larson, J Macalalag, L Narahara, M Payne, M Seiff, S Wilson, S Woodring, H Davis, J Mendez, P Murray, T Simmons, T van der Horst, C Kylstra, J Wohl, D Ziman, K Pavan, PR Bergen, GA Cohen, SM Craig, JA Dehler, RL Elbert, E Fox, RW Grizzard, WS Hammer, ME Hernandez, LS Herrera, S Holt, D Kemp, S Larkin, JA Ledford, DK Lockey, RF Menosky, MM Millard, S Nadler, JP Nelson, RP Norris, D Ormerod, LD Pautler, SE Poblete, SJ Rodriguez, D Rosenbach, KP Seekins, DW Toney, JR Jabs, DA Dodge, JM Klemstine, JL Schuerholtz, TA Stevens, M Meinert, CL Amend-Libercci, D Coleson, L Collins, KL Collison, BJ Dawson, C Dodge, J Donithan, M Ewing, C Fink, N Gerczak, C Harle, J Holbrook, JT Huffman, R Isaacson, MR Gilpin, AMK Lane, M Levine, CR Martin, B Meinert, J Nowakowski, DJ Owens, RM Piantadosi, B Saah, A Smith, M Tonascia, J Van Natta, ML Davis, MD Armstrong, J Brickbauer, J Brothers, R Chop, M Hubbard, L Hurlburt, D Kastorff, L Magli, Y Neider, M Onofrey, J Stoppenbach, V Vanderhoof-Young, M Walls, M Hughes, R Kurinij, N Mowery, RL Alston, B Foulkes, M Jabs, DA Davis, MD Kurinij, N Meinert, CL Mowery, RL Jabs, DA Addessi, A Alston, B Clark, T Davis, MD Feinberg, J Freeman, W Holbrook, J Holland, GN Hubbard, L Jacobson, M Kurinij, N Lewis, RA McArthur-Chang, L Meinert, C Mowery, R Murphy, R Polsky, B Tonascia, J Jabs, DA Davis, MD Duncan, WR Feinberg, J Kessler, H Kurinij, N Lambert, AG Meinert, CL Mowery, RL Powderly, W Schnittman, S Spector, S Tonascia, J Brown, BW Conway, B Grizzle, J Nussenblatt, R Phair, JP Smith, H Whitley, R Alston, B Davis, MD Foulkes, M Jabs, DA Kurinij, N Meinert, CL Mowery, RL Tonascia, J Jabs, DA Freeman, WR Jacobson, M Murphy, R Van Natta, ML Meinert, CL Cheng, B Frost, K Lambert, AG Marco, M
Citation: Ra. Lewis et al., Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial - The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group, AIDS, 14(11), 2000, pp. 1571-1581
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice
Authors: Jabs, DA Lee, B Whittum-Hudson, JA Prendergast, RA
Citation: Da. Jabs et al., Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice, INV OPHTH V, 41(3), 2000, pp. 826-831
Risk factors for advancement of cytomegalovirus retinitis in patients withacquired immunodeficiency syndrome
Authors: Holbrook, JT Davis, MD Hubbard, LD Martin, BK Holland, GN Jabs, DA Gilpin, AK Meinert, C Reshef, DS
Citation: Jt. Holbrook et al., Risk factors for advancement of cytomegalovirus retinitis in patients withacquired immunodeficiency syndrome, ARCH OPHTH, 118(9), 2000, pp. 1196-1204
Optic disc sarcoid granuloma
Authors: Farr, AK Jabs, DA Green, WR
Citation: Ak. Farr et al., Optic disc sarcoid granuloma, ARCH OPHTH, 118(5), 2000, pp. 728-729
Episcleritis and scleritis: Clinical features and treatment results
Authors: Jabs, DA Mudun, A Dunn, JP Marsh, MJ
Citation: Da. Jabs et al., Episcleritis and scleritis: Clinical features and treatment results, AM J OPHTH, 130(4), 2000, pp. 469-476
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
Authors: Jabs, DA Rosenbaum, JT Foster, CS Holland, GN Jaffe, GJ Louie, JS Nussenblatt, RB Stiehm, ER Tessler, H Van Gelder, RN Whitcup, SM Yocum, D
Citation: Da. Jabs et al., Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel, AM J OPHTH, 130(4), 2000, pp. 492-513
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy
Authors: Nguyen, QD Kempen, JH Bolton, SG Dunn, JP Jabs, DA
Citation: Qd. Nguyen et al., Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy, AM J OPHTH, 129(5), 2000, pp. 634-639
Overview of HIV/AIDS ocular manifestations
Authors: Jabs, DA
Citation: Da. Jabs, Overview of HIV/AIDS ocular manifestations, HIV AND THE EYE, 2000, pp. 61-80
Pars planitis - Clinical features and class II HLA associations
Authors: Raja, SC Jabs, DA Dunn, JP Fekrat, S Machan, CH Marsh, MJ Bressler, NM
Citation: Sc. Raja et al., Pars planitis - Clinical features and class II HLA associations, OPHTHALMOL, 106(3), 1999, pp. 594-599
Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis
Authors: Jabs, DA Forman, M Enger, C Jackson, JB
Citation: Da. Jabs et al., Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis, J CLIN MICR, 37(5), 1999, pp. 1431-1435
Risultati: 1-25 | 26-29